Alembic Limited announced that Mr. C. P. Buch has completed his second consecutive term of five years as an Independent Director and consequently ceases to be a Director of the Company with effect from end of the day on 31st March, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.29 INR | +0.43% | +0.63% | +4.06% |
Apr. 18 | Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3% | MT |
Apr. 02 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
1st Jan change | Capi. | |
---|---|---|
+4.06% | 290M | |
+40.37% | 27.94B | |
-13.26% | 26.97B | |
+21.99% | 26.95B | |
+0.89% | 25.32B | |
+49.90% | 22.58B | |
+2.78% | 19.59B | |
+4.36% | 19.52B | |
+31.00% | 16.23B | |
-14.03% | 14.98B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Announces Cessation of C. P. Buch as an Independent Director